DUBLIN--(BUSINESS WIRE)--The "Global Apheresis Market - Segmented by Applications, Types of Procedures, Technology and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The apheresis market is expected to grow at a CAGR of about 7.7% during the forecast period.
Growing Demand for Plasma
Chinese patients consumed nearly 300 tonnes of serum albumin in 2016 which is half of the overall global consumption. About 60 per cent of that was imported, and demand is growing at 15 per cent annually. This constantly increasing demand for human plasma will lead to a rapid growth in the apheresis market.
Other factors that will drive the market in the future include growing number of platelet donors, improving healthcare infrastructure in emerging economies and reimbursement policies.
Key Highlights
- Lack of Trained Professionals - Negatively Affecting Growth
- North America to Maintain Dominance
Major Market Development
- Spectral Medical received FDA 510(k) clearance for its Spectral Apheresis Machine designed for use in continuous renal replacement therapy and therapeutic plasma.
Companies Featured
- Asahi Kasei Corporation
- B. Braun Melsungen AG
- Cerus Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Hemacare Corporation
- Kaneka Corporation
- Kawasumi Laboratories Inc.
- Terumo Corporation
- Therakos Inc.
Key Topics Covered
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/pgq2w4/global_apheresis?w=4
